HealthCap | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/HealthCap/Activity

HealthCap Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Talk

HealthCap highlighted Hemab presenting new clinical data and introducing HMB-003 at ISTH 2026.

Hemab Therapeutics

Hemab Therapeutics HealthCap

healthcap.euJUL 12, 2026

JUL 12, 2026

Investment

HealthCap led the investment in Neobiomics to support continued growth in neonatal care.

Neobiomics

Neobiomics HealthCap

healthcap.euMAY 20, 2026

MAY 20, 2026

News

Intervacc announced that Jonas Sohlman would leave as CEO and Carl-Johan Dalsgaard was appointed CEO.

Intervacc

Intervacc HealthCap

healthcap.euFEB 5, 2026

FEB 5, 2026

Exit

Fusion Pharmaceuticals was acquired by AstraZeneca for up to USD 2.4 billion.

Fusion Pharmaceuticals

Fusion Pharmaceuticals HealthCap

healthcap.euMAR 19, 2024

MAR 19, 2024